358 related articles for article (PubMed ID: 16010846)
1. Candida biofilm: a well-designed protected environment.
Mukherjee PK; Zhou G; Munyon R; Ghannoum MA
Med Mycol; 2005 May; 43(3):191-208. PubMed ID: 16010846
[TBL] [Abstract][Full Text] [Related]
2. Pathogenesis of Candida albicans biofilm.
Tsui C; Kong EF; Jabra-Rizk MA
Pathog Dis; 2016 Jun; 74(4):ftw018. PubMed ID: 26960943
[TBL] [Abstract][Full Text] [Related]
3. Biofilm of Candida albicans: formation, regulation and resistance.
Pereira R; Dos Santos Fontenelle RO; de Brito EHS; de Morais SM
J Appl Microbiol; 2021 Jul; 131(1):11-22. PubMed ID: 33249681
[TBL] [Abstract][Full Text] [Related]
4. Development of Anti-Virulence Approaches for Candidiasis via a Novel Series of Small-Molecule Inhibitors of
Romo JA; Pierce CG; Chaturvedi AK; Lazzell AL; McHardy SF; Saville SP; Lopez-Ribot JL
mBio; 2017 Dec; 8(6):. PubMed ID: 29208749
[No Abstract] [Full Text] [Related]
5. How to build a biofilm: a fungal perspective.
Blankenship JR; Mitchell AP
Curr Opin Microbiol; 2006 Dec; 9(6):588-94. PubMed ID: 17055772
[TBL] [Abstract][Full Text] [Related]
6. Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance.
Chandra J; Kuhn DM; Mukherjee PK; Hoyer LL; McCormick T; Ghannoum MA
J Bacteriol; 2001 Sep; 183(18):5385-94. PubMed ID: 11514524
[TBL] [Abstract][Full Text] [Related]
7. Proteomics for the analysis of the Candida albicans biofilm lifestyle.
Thomas DP; Bachmann SP; Lopez-Ribot JL
Proteomics; 2006 Nov; 6(21):5795-804. PubMed ID: 17001605
[TBL] [Abstract][Full Text] [Related]
8. Relative Abundances of Candida albicans and Candida glabrata in
Olson ML; Jayaraman A; Kao KC
Appl Environ Microbiol; 2018 Apr; 84(8):. PubMed ID: 29427422
[No Abstract] [Full Text] [Related]
9. Antifungal susceptibility of Candida albicans in biofilms.
Tobudic S; Kratzer C; Lassnigg A; Presterl E
Mycoses; 2012 May; 55(3):199-204. PubMed ID: 21793943
[TBL] [Abstract][Full Text] [Related]
10. Candida species isolated from different body sites and their antifungal susceptibility pattern: Cross-analysis of Candida albicans and Candida glabrata biofilms.
Cataldi V; Di Campli E; Fazii P; Traini T; Cellini L; Di Giulio M
Med Mycol; 2017 Aug; 55(6):624-634. PubMed ID: 27915303
[TBL] [Abstract][Full Text] [Related]
11. Antifungal activity against Candida biofilms.
Iñigo M; Pemán J; Del Pozo JL
Int J Artif Organs; 2012 Oct; 35(10):780-91. PubMed ID: 23138707
[TBL] [Abstract][Full Text] [Related]
12. A histone deacetylase complex mediates biofilm dispersal and drug resistance in Candida albicans.
Nobile CJ; Fox EP; Hartooni N; Mitchell KF; Hnisz D; Andes DR; Kuchler K; Johnson AD
mBio; 2014 Jun; 5(3):e01201-14. PubMed ID: 24917598
[TBL] [Abstract][Full Text] [Related]
13.
Ponde NO; Lortal L; Ramage G; Naglik JR; Richardson JP
Crit Rev Microbiol; 2021 Feb; 47(1):91-111. PubMed ID: 33482069
[No Abstract] [Full Text] [Related]
14. Bioluminescence Imaging to Study Mature Biofilm Formation by Candida spp. and Antifungal Activity In Vitro and In Vivo.
Van Dyck K; Van Dijck P; Vande Velde G
Methods Mol Biol; 2020; 2081():127-143. PubMed ID: 31721122
[TBL] [Abstract][Full Text] [Related]
15. Candida albicans biofilm-induced vesicles confer drug resistance through matrix biogenesis.
Zarnowski R; Sanchez H; Covelli AS; Dominguez E; Jaromin A; Bernhardt J; Mitchell KF; Heiss C; Azadi P; Mitchell A; Andes DR
PLoS Biol; 2018 Oct; 16(10):e2006872. PubMed ID: 30296253
[TBL] [Abstract][Full Text] [Related]
16. Sustained Nitric Oxide-Releasing Nanoparticles Induce Cell Death in Candida albicans Yeast and Hyphal Cells, Preventing Biofilm Formation In Vitro and in a Rodent Central Venous Catheter Model.
Ahmadi MS; Lee HH; Sanchez DA; Friedman AJ; Tar MT; Davies KP; Nosanchuk JD; Martinez LR
Antimicrob Agents Chemother; 2016 Apr; 60(4):2185-94. PubMed ID: 26810653
[TBL] [Abstract][Full Text] [Related]
17. Global Identification of Biofilm-Specific Proteolysis in Candida albicans.
Winter MB; Salcedo EC; Lohse MB; Hartooni N; Gulati M; Sanchez H; Takagi J; Hube B; Andes DR; Johnson AD; Craik CS; Nobile CJ
mBio; 2016 Sep; 7(5):. PubMed ID: 27624133
[TBL] [Abstract][Full Text] [Related]
18. Candida albicans
Rollenhagen C; Agyeman H; Eszterhas S; Lee SA
mSphere; 2021 Oct; 6(5):e0070721. PubMed ID: 34585966
[TBL] [Abstract][Full Text] [Related]
19. Proteomic analysis uncovers the modulation of ergosterol, sphingolipid and oxidative stress pathway by myristic acid impeding biofilm and virulence in Candida albicans.
Prasath KG; Sethupathy S; Pandian SK
J Proteomics; 2019 Sep; 208():103503. PubMed ID: 31454558
[TBL] [Abstract][Full Text] [Related]
20. Functional Genomic Analysis of Candida albicans Adherence Reveals a Key Role for the Arp2/3 Complex in Cell Wall Remodelling and Biofilm Formation.
Lee JA; Robbins N; Xie JL; Ketela T; Cowen LE
PLoS Genet; 2016 Nov; 12(11):e1006452. PubMed ID: 27870871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
